• Worst Pills, Best Pills



• Health Letter



• Health Links



• Activist Courses



• Take Action!



• Drug Safety



• Healthcare Delivery



• Medical Devices



• Food Safety



• Occupational Health

Publications:

» (6/13/07) Testimony Before FDA Advisory Committee Meeting on Rimonabant (HRG Publication #1815) » (4/19/07) Comments on FDA Obesity Trial Guidelines (HRG Publication #1808) » (6/15/06) Statement Before the Institute of Medicine Committee on Developing Cancer Biomarkers: A Case Study Involving ACF/orlistat (HRG Publication #1773) » (6/5/06) Supplement to petition to ban diet drug orlistat (XENICAL). Additional information provided about pre-cancerous changes to the colon (HRG Publication #1771) » (4/10/06) Petition to the FDA to immediately remove the diet drug orlistat (XENICAL) from the market (HRG Publication #1764) » (1/23/06) Testimony Before the FDA Advisory Committees on Possible Switch of Orlistat (XENICAL) to OTC Status (HRG Publication #1760) » (8/17/05) FDA Denial of Public Citizen’s Petition to Ban Meridia Is Misguided (HRG Publication #1748) » (9/3/03) Petition supplement to FDA outlining the rising number of cardiovascular events associated with the diet drug sibutramine (MERIDIA) (HRG Publication #1675) » (5/21/02) Letter to HHS urging that criminal charges be brought against Abbott Laboratories for illegally withholding information concerning eight deaths and other adverse effects of the drug sibutramine (MERIDIA) (HRG Publication #1619) » (3/19/02) Petition to FDA to ban the diet drug sibutramine (MERIDIA) (HRG Publication #1613) » (10/19/00) Petition to the Food and Drug Administration requesting an immediate ban of all uses of Phenylpropanolamine (PPA) in over-the-counter products. (HRG Publication #1542) » (5/14/97) Comments before the Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory Committee on orlistat (Xenical) for the treatment of obesity. (HRG Publication #1417) » (4/29/96) Letter to FD Commissioner David Kessler Urging Him to Delay Approval of the Weight Control Drug Dexfenfluramine (HRG Publication #1389)

more resources

Because Public Citizen does not accept funds from corporations, professional associations or government agencies, we can remain independent and follow the truth wherever it may lead. But that means we depend on the generosity of concerned citizens like you for the resources to fight on behalf of the public interest. If you would like to help us in our fight, click here.